Blog

CDC authorizes COVID-19 vaccines for children 5-11 years of age

Tags: Health
  • Blog

    CDC authorizes COVID-19 vaccines for children 5-11 years of age

    On November 2, the Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 5-11 following the Food and Drug Administration’s (FDA) recommendation. The CDC’s endorsement follows the FDA’s recommendation on October 29 to authorize emergency use of the Pfizer-BioNTech COVID-19 vaccine to include children 5-11 years of age.

    The FDA’s decision comes after it was determined the vaccine was approximately 91 percent effective in preventing COVID-19 in children 5-11 years of age. Children within this age group account for 39 percent of COVID-19 cases in individuals younger than 18 years of age across the nation. An ongoing study discovered no serious side effects in approximately 3,100 children aged 5-11 who received the COVID-19 vaccine.

    On October 14, the CDC released a Pediatric COVID-19 Vaccination Operational Planning Guide, which highlights key differences between adult and adolescent vaccination programs and those that are designed for children. The National Association of County and City Health Officials (NACCHO) has provided a summary of the guide and pulled out high-level considerations for county health departments, as key components of pediatric COVID-19 vaccination planning in local communities.

    As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported over 192 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters. For more information on how county health facilities can prepare for the distribution of COVID-19 vaccines for children, and COVID-19 boosters, see NACo’s COVID-19 Vaccine Distribution Toolkit.

    ADDITIONAL RESOURCES

    • NACo’s COVID-19 Vaccine Distribution Toolkit
    • NACo Brief: The County Role in Vaccines
    • NACo Blog: FDA approves Pfizer and Moderna booster doses, authorizes mix and match for COVID-19 vaccines

    On November 2, the Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 5-11 following the Food and Drug Administration’s (FDA) recommendation.
    2021-11-05
    Blog
    2021-11-05
CDC approves use of Pfizer-BioNTech COVID-19 vaccine for children after FDA determines it is 91 percent effective in children aged 5-11 County health departments will play a key role in local COVID-19 vaccination planning for children aged 5-11

On November 2, the Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 5-11 following the Food and Drug Administration’s (FDA) recommendation. The CDC’s endorsement follows the FDA’s recommendation on October 29 to authorize emergency use of the Pfizer-BioNTech COVID-19 vaccine to include children 5-11 years of age.

The FDA’s decision comes after it was determined the vaccine was approximately 91 percent effective in preventing COVID-19 in children 5-11 years of age. Children within this age group account for 39 percent of COVID-19 cases in individuals younger than 18 years of age across the nation. An ongoing study discovered no serious side effects in approximately 3,100 children aged 5-11 who received the COVID-19 vaccine.

On October 14, the CDC released a Pediatric COVID-19 Vaccination Operational Planning Guide, which highlights key differences between adult and adolescent vaccination programs and those that are designed for children. The National Association of County and City Health Officials (NACCHO) has provided a summary of the guide and pulled out high-level considerations for county health departments, as key components of pediatric COVID-19 vaccination planning in local communities.

As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported over 192 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters. For more information on how county health facilities can prepare for the distribution of COVID-19 vaccines for children, and COVID-19 boosters, see NACo’s COVID-19 Vaccine Distribution Toolkit.

ADDITIONAL RESOURCES

  • Basic page

    The Stepping Up Initiative

    In May 2015, NACo and partners at the CSG Justice Center and APA Foundation launched Stepping Up: A National Initiative to Reduce the Number of People with Mental Illnesses in Jails.
    page

    <h2>Overview</h2>

    <blockquote>
    <h3>Join the Initiative!</h3>

  • Reports & Toolkits

    COVID-19 Recovery Clearinghouse

    The COVID-19 Recovery Clearinghouse features timely resources for counties, including allocation estimations, examples of county programs using federal coronavirus relief funds, the latest news and more.
    03
    12
    7:15 pm
    Reports & Toolkits

    <table border="1" cellpadding="1" cellspacing="1" style="width:100%" summary="ad-block no-top-margin no-bullets">
    <caption>Jump to Section</caption>

  • Basic page

    Live Healthy U.S. Counties

    The National Association of Counties (NACo) Live Healthy Prescription, Health & Dental Discount Program is a NO-COST program available to all member counties.
    page

    <h1>With <a id="naco" name="naco">NACo</a>, Saving Feels Better</h1>

Related Posts

Related Resources

More From